These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Omalizumab markedly improves urticaria activity scores and quality of life scores in chronic spontaneous urticaria patients: a real life survey. Büyüköztürk S; Gelincik A; Demirtürk M; Kocaturk E; Colakoğlu B; Dal M J Dermatol; 2012 May; 39(5):439-42. PubMed ID: 22221177 [TBL] [Abstract][Full Text] [Related]
27. Successful treatment of 3 patients with recurrent idiopathic angioedema with omalizumab. Sands MF; Blume JW; Schwartz SA J Allergy Clin Immunol; 2007 Oct; 120(4):979-81. PubMed ID: 17931567 [No Abstract] [Full Text] [Related]
28. Omalizumab as a therapeutic alternative for chronic urticaria. Callejas-Rubio JL; Sánchez-Cano D; Lara MA; Ortego-Centeno N Ann Allergy Asthma Immunol; 2008 Nov; 101(5):556. PubMed ID: 19055216 [No Abstract] [Full Text] [Related]
29. What are the effects of omalizumab in refractory chronic spontaneous urticaria? López M; Navajas-Galimany L Medwave; 2015 Dec; 15 Suppl 3():e6346. PubMed ID: 26731420 [TBL] [Abstract][Full Text] [Related]
30. Effective treatment of refractory severe heat urticaria with omalizumab. Bullerkotte U; Wieczorek D; Kapp A; Wedi B Allergy; 2010 Jul; 65(7):931-2. PubMed ID: 19930230 [No Abstract] [Full Text] [Related]
31. [Argentine guidelines for urticaria and angioedema]. Máspero J; Cabrera H; Ardusso L; De Gennaro M; Fernández Bussy R; Galimany J; Galimberti D; Label M; La Forgia M; Medina I; Neffen H; Troielli P; ; Medicina (B Aires); 2014; 74 Suppl 1():1-53. PubMed ID: 25202880 [TBL] [Abstract][Full Text] [Related]
32. Successful treatment of occupational delayed pressure urticaria and angioedema with omalizumab. Geller M Ann Allergy Asthma Immunol; 2016 Jan; 116(1):81-2. PubMed ID: 26602491 [No Abstract] [Full Text] [Related]
33. A critical appraisal of omalizumab as a therapeutic option for chronic refractory urticaria/angioedema. Lang DM Ann Allergy Asthma Immunol; 2014 Apr; 112(4):276-9. PubMed ID: 24589165 [No Abstract] [Full Text] [Related]
34. Omalizumab therapy in three patients with chronic autoimmune urticaria. Al-Ahmad M Ann Saudi Med; 2010; 30(6):478-81. PubMed ID: 20864790 [TBL] [Abstract][Full Text] [Related]
36. Effect of omalizumab on patients with chronic urticaria. Spector SL; Tan RA Ann Allergy Asthma Immunol; 2007 Aug; 99(2):190-3. PubMed ID: 17718108 [TBL] [Abstract][Full Text] [Related]
37. Partial improvement of solar urticaria after omalizumab. Waibel KH; Reese DA; Hamilton RG; Devillez RL J Allergy Clin Immunol; 2010 Feb; 125(2):490-1. PubMed ID: 20159260 [No Abstract] [Full Text] [Related]
38. Co-Occurrence of Chronic Spontaneous Urticaria with Immunoglobulin A Deficiency and Autoimmune Diseases. Frossi B; De Carli S; Bossi F; Pucillo C; De Carli M Int Arch Allergy Immunol; 2016; 169(2):130-4. PubMed ID: 27073906 [TBL] [Abstract][Full Text] [Related]
39. Chronic urticaria: omalizumab and review of therapeutic options. Bergstrom KG J Drugs Dermatol; 2013 Jun; 12(6):715-6. PubMed ID: 23839196 [TBL] [Abstract][Full Text] [Related]
40. Therapeutic alternatives for chronic urticaria: additional reports on omalizumab. Spector SL; Tan RA Ann Allergy Asthma Immunol; 2008 Dec; 101(6):647. PubMed ID: 19119713 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]